Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19

Abstract

Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19.

Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era

“…To extend our scientific evidence and authors' contributions from the previous two article collections Novel Therapeutic Approaches in Nephrology and Hypertension in the Current Opinion in Nephrology and Hypertension in January 2020 and January 2021, which focused on novel therapeutic approaches to prolong and preserve the function of native kidneys [4][5][6][7][8][9][10][11][12][13][14][15] and kidney allografts and kidney health and novel management strategies for common metabolic conditions related to CKD, end-stage kidney disease (ESKD), and kidney transplantation [16][17][18][19][20][21][22][23][24][25][26][27], respectively, the January 2022 article collection in the current issue of Current Opinion in Nephrology and Hypertension introduces novel and renewed multimodal approaches in the form of integrated therapeutic strategies for CKD, kidney failure, and transplantation and some practical and individualized approaches, with overarching spectureum from diet and lifestyle modification to emerging pharmacotherapy.…”